ابعاد کنترل روانشناختی والدین: ارتباطات با پرخاشگری فیزیکی و رابطه پیش دبستانی در روسیه
|کد مقاله||سال انتشار||مقاله انگلیسی||ترجمه فارسی||تعداد کلمات|
|34396||1997||11 صفحه PDF||سفارش دهید||5069 کلمه|
Publisher : Elsevier - Science Direct (الزویر - ساینس دایرکت)
Journal : Schizophrenia Research, Volume 26, Issues 2–3, 29 August 1997, Pages 127–137
Aims: To compare the performance of schizophrenia, mania and well control groups on tests sensitive to impaired executive ability, and to assess the within-group stability of these measures across the acute and subacute phases of psychoses. Method: Recently admitted patients with schizophrenia (n=36), mania (n=18) and a well control group (n=20) were assessed on two occasions separated by 4 weeks. Tests included: the Controlled Oral Word Association Test, the Stroop Test, the Wisconsin Card Sort Test, and the Trail Making Test. Results: The two patient groups were significantly impaired on the Stroop Test at both time points compared to the control group. Significant group differences were also found for the Trail Making Test at Time 1 and for the Wisconsin Card Sort Test at Time 2. When controlled for practice effect, significant improvements over time were found on the Stroop and Trail Making tests in the schizophrenia group and on WCST Categories Achieved in the mania group. Discussion: Compared to controls, the patient groups were impaired on measures related to executive ability. The pattern of improvement on test scores between the acute and subacute phases differed between patients with schizophrenia versus patients with mania.
The summary term `executive ability' has achieved widespread acceptance in neuropsychology, behavioural neurology and neuropsychiatry. Stuss and Benson (1986, p. 222) have listed key neurocognitive deficits associated with impaired executive ability: 1. `Deficit in the ordering or handling of sequential behaviour. 2. Impairment in establishing or changing set. 3. Impairment in maintaining a set, particularly in the presence of interference. 4. Decreased ability to monitor personal behaviour. 5. Dissociation of knowledge from the direction of response. 6. Altered attitudes'. Dysfunction of the prefrontal systems is typically associated with impaired executive ability; however, efficient executive ability requires the dynamic integration (`orchestration') of cognitive skills whose neurobiological substrates appear to be widely distributed across cortical and subcortical regions. Patients with schizophrenia have been noted to have impaired performance on tests of executive ability as judged by measures such as the Wisconsin Card Sort Test (WCST), the Trail Making Test (TMT), tests of verbal fluency and the Stroop Test (Goldberg et al., 1989; Levin et al., 1989). Similar deficits have also been described in mania (Morice, 1990; Yurgelun-Todd, 1988). Whether deficits of executive ability are more pronounced than other neurocognitive deficits has been a matter of debate. While there is considerable evidence demonstrating impairments in executive ability, attention and memory in schizophrenia, these patients tend to have impaired performance on most psychometric measures when compared to well controls, and it can be difficult to isolate specific elements as being differentially impaired (Levin et al., 1989; Gold and Harvey, 1993). In part this relates to the sensitivity and specificity of the tests of executive ability (Heinrichs, 1990; Axelrod et al., 1994). Impaired performance on tests related to executive ability can be a direct consequence of an isolated deficit in executive ability, or an indirect manifestation related to more widespread cognitive dysfunction (e.g., impaired attention, global dementia). In other words, poor performance on tests of executive ability does not necessarily indicate an isolated cognitive dysfunction. In this paper the slightly unwieldy phrase `tests sensitive to impaired executive ability' will be used to indicate this conceptual issue. Regardless of the specificity of the deficit, clinicians frequently recognise behaviours listed by Stuss and Benson (1986)in their patients. When the general term `executive ability' is fractionated into behaviours such as poor planning ability, inability to maintain set in the face of distraction, and impaired ability to monitor personal behaviour, the concept takes on considerable clinical utility. With respect to psychiatric rehabilitation, a recent review suggested that executive ability was a good predictor of the level of subsequent community functioning in schizophrenia (Green, 1996). While there is a large body of literature demonstrating differential performance on tests sensitive to impaired executive ability in schizophrenia compared to well controls, less data are available on the longitudinal course of this deficit. Determining the `state versus trait' components of this deficit would be of interest, as perhaps stable trait deficits would be better predictors of potential for rehabilitation than fluctuating state markers. If elements related to executive ability are state-related, charting the trajectory of these cognitive abilities over time would be of interest. The following section briefly reviews literature reporting the longitudinal performance of individuals with schizophrenia on tests sensitive to impaired executive ability. Key elements of the literature are summarised in Table 1. Table 1. Summary of studies reporting the stability of selected measures sensitive to impaired executive ability in schizophrenia (and controls) Study Groups/sample size Interventions Test–retest interval Measures of executive ability Results Seidman et al. (1991) (a) Scz=12 (a) Standard clinical care (a) 6 months–7 years WCST No significant difference on WCST found in either group (b) Scz=10 (b) Neuroleptic reduction (b) 3–15 months Addington et al. (1991) Scz=38 Standard clinical care 6 months WCST, VF WCST no change. Improvement on one VF task Sweeney et al. (1991) Scz=39 Standard clinical care 1 year WCST, TMT, VF Better on WCST but not VF Nopoulos et al. (1994) (a) Scz=35 Standard clinical care (a) 1-year or 2-year interval Stroop, TMT, VF Better on Stroop and TMT but not VF (b) Controls=68 (b) Control group not retested Buchanan et al. (1994a) (a) Scz=38 (a) Clozapine vs. haloperidol (a) 10 weeks VF, TMT, WCST, Stroop (a) Worsening of VF in haloperidol group (b) Scz=33 (b) Open label clozapine (b) 1 year (b) Improved on VF and TMT only Hagger et al. (1993) (a) Scz=36 Open label clozapine (a) 6 weeks and 6 months VF, WCST Improvements on VF at both time points (b) Controls=26 (b) Control group not retested Verdoux et al. (1995) (a) Scz=18 Standard clinical care. Baseline measures collected when patients were neuroleptic free 1–3 months VF, Stroop, WCST Both schizophrenia and controls improved on VF and Stroop. Controls improved on WCST perseverative error (b) Control=18 Scz=schizophrenia; WCST=Wisconsin Card Sort Test; VF=Verbal fluency; TMT=Trail making test. Table options Seidman et al. (1991)found no significant differences on scores derived from the WCST in 12 patients with schizophrenia who were tested on two occasions separated by variable intervals of between 6 months and 7 years. In the same article, Seidman and colleagues examined the stability of performance on the WCST in a group of 10 patients with schizophrenia after dose reduction of antipsychotic medication. The interval between testing varied between 3 and 15 months (mean 6 months). Once again, there were no significant differences across time. The authors of this study noted that scores for some patients did change over time, suggesting that group averaging may mask heterogeneity in the stability of executive ability. Addington et al. (1991)examined performance on a range of neuropsychological tests (including measures of executive ability such as the WCST and two word fluency tasks) in a group of 38 patients with schizophrenia who were tested within 1 week of admission and again 6 months later. Neither the WCST Categories Achieved scores nor the WCST Perseverative Error scores showed any significant change over time; however, performance on one of the verbal fluency tasks improved significantly. Sweeney et al. (1991)presented evidence of improvement on the WCST Categories Achieved and Perseverative Error scores and on the TMT. Verbal fluency showed no change. Their group included 39 patients with schizophrenia tested initially just prior to discharge (after an acute admission) and again 1 year later. Patients with tardive dyskinesia or who were on high potency antipsychotics were not included in the study, and subjects who relapsed within 3 months of discharge were also excluded from the study. A well control group (n=68) was included in a study by Nopoulos et al. (1994). This study examined 35 patients with onset of schizophrenia within the previous 5 years. Most patients had been recruited during an acute hospitalisation and all were considered to be in an active phase of their illness when first assessed. Of the original sample, 17 patients were retested 1 year later, and 18 patients were retested 2 years later. The well controls were not retested. Significant improvements were noted on the Stroop test and the TMT, but not on verbal fluency. The authors acknowledged that the lack of follow-up testing for the control group was a limitation of the study, as practice effects need to be considered when assessing the stability of cognitive functioning over time. With the availability of new, atypical antipsychotic medications, and the realisation of the importance of the effect of medication on neurocognitive measures, we can expect to see more research detailing the impact of these products on executive ability. Buchanan et al. (1994a)examined the impact of clozapine on executive ability using measures such as the WCST Perseverative Error score, verbal fluency, the Stroop test and the TMT. Testing was undertaken at baseline, at the end of a 10-week double-blind trial of clozapine versus haloperidol, and again at 1 year after an open-label follow-up extension of clozapine. Data were available on 38 subjects at the 10-week retest. There were no significant changes on any of the measures, apart from a worsening of performance on verbal fluency in the haloperidol-treated group. Thirty-three patients were retested at 1 year after open-label clozapine. This group showed significant improvement on verbal fluency and the TMT, but had no significant improvement on the WCST Perseverative Error score nor on the Stroop test. In another open-label study of clozapine, Hagger et al. (1993)tested 36 treatment-refractory patients with schizophrenia at baseline and after 6 weeks and 6 months of treatment. The test battery included verbal fluency, and the WCST Categories Achieved and Perseverative Error scores. Significant improvement was noted on verbal fluency at both retests, but there were no significant changes in the WCST scores. A well control group was tested at baseline, but not at subsequent intervals. The potential impact of practice effect on tests sensitive to executive ability was acknowledged in the study by Verdoux et al. (1995). A group of 18 neuroleptic-free patients with schizophrenia was tested in the first few days after admission and again after at least 4 weeks on neuroleptic medication. The interval between testing ranged from 1 to 3 months (apart from one subject who was retested over 14 months later). A well control group was tested on two occasions separated by 2–3 months. Both the schizophrenia and the well control group improved on verbal fluency and Stroop scores. In addition, the well controls showed significant improvement on the WCST Perseverative Error score. This study demonstrates the importance of including a well control group at both testing sessions in order to identify practice effects. However, Verdoux and colleagues do not comment on whether the patient's improvements in executive ability persisted after the practice effect was taken into account. There is a paucity of research on the longitudinal course of executive ability in mania; however, the available data suggest that certain general cognitive functions do improve over time (Bulbena and Berrios, 1993). The aims of the present study were to compare the performance of schizophrenia, mania and well control groups on tests sensitive to impaired executive ability, and to assess the within-group stability of these measures across the acute and subacute phases of psychoses when controlled for practice effect.